Drug Research
Adimab, Innovent collaborate on discovery, commercialization of antibody-based therapeutic
Adimab and Innovent have collaborated to discover, develop and commercialise an antibody-based therapeutic, using Adimab antibody discovery and optimization platform, against a selected specific target....
Drug Research
Supernus to launch Trokendi extended release formulation to treat...
Specialty pharmaceutical company Supernus Pharmaceuticals is set to launch once-daily extended release formulation of topiramate, Trokendi XR, to treat epilepsy following the final FDA approval....
Drug Research
Takeda announces availability of type 2 diabetes drugs in...
Takeda Pharmaceutical Company has announced the availability of NESINA (alogliptin) and fixed-dose combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone) by prescription...
Drug Research
Amedra re-launches Adrenaclick to treat anaphylaxis
Amedra Pharmaceuticals has re-launched a single-dose epinephrine auto-injector Adrenaclick for people with increased risk of anaphylaxis in both 0.15mg and 0.30mg strengths. ...
Drug Research
Eisai to market and distribute Belviq weight management therapy...
Eisai has announced the availability of Belviq (lorcaserin HCl) CIV tablets in the US, which is designed for chronic weight management in adults who are...
Drug Research
Johnson & Johnson opens California Innovation Center
Johnson & Johnson (J&J) Innovation has opened the new California Innovation Center to build early stage collaborations with emerging companies in science and technology and...
Drug Research
Second Genome signs microbiome drug discovery deal with Janssen
Second Genome has signed a microbiome drug discovery deal with Janssen Biotech to advance novel drug targets mediated by the bacterial ecosystem living within the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.